OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma
Michael E. Wechsler, Ghislaine Scélo, Désirée Larenas‐Linnemann, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 209, Iss. 3, pp. 262-272
Open Access | Times Cited: 24
Michael E. Wechsler, Ghislaine Scélo, Désirée Larenas‐Linnemann, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 209, Iss. 3, pp. 262-272
Open Access | Times Cited: 24
Showing 24 citing articles:
Association between pre-biologic T2-Biomaker combinations and response to biologics in patients with severe asthma
Celeste Porsbjerg, Jonathan N. Townend, Céline Bergeron, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Celeste Porsbjerg, Jonathan N. Townend, Céline Bergeron, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Integrative Roles of Pro‐Inflammatory Cytokines on Airway Smooth Muscle Structure and Function in Asthma
Maria L. Ford, Mohammad Irshad Reza, Anushka Ruwanpathirana, et al.
Immunological Reviews (2025) Vol. 330, Iss. 1
Open Access | Times Cited: 1
Maria L. Ford, Mohammad Irshad Reza, Anushka Ruwanpathirana, et al.
Immunological Reviews (2025) Vol. 330, Iss. 1
Open Access | Times Cited: 1
Real-world comparison of T2-biologics effectiveness in severe allergic asthma with nasal polyps
Angélica Tiotiu, Nicolas Migueres, Francisco Javier González‐Barcala, et al.
Respiratory Medicine (2025) Vol. 238, pp. 107979-107979
Closed Access
Angélica Tiotiu, Nicolas Migueres, Francisco Javier González‐Barcala, et al.
Respiratory Medicine (2025) Vol. 238, pp. 107979-107979
Closed Access
Eosinophilic chronic rhinosinusitis as a predictor of super-responder and clinical remission in patients with uncontrolled type 2-high severe asthma treated with biologics
Satoshi Hamada, Eriko Ogino, Hirotaka Yasuba
Respiratory Investigation (2025) Vol. 63, Iss. 3, pp. 247-251
Closed Access
Satoshi Hamada, Eriko Ogino, Hirotaka Yasuba
Respiratory Investigation (2025) Vol. 63, Iss. 3, pp. 247-251
Closed Access
Asthma Exacerbation Comorbidity Index (AECI): Predicting In-Hospital Adverse Outcomes
Chongyang Zhao, Gang Wang, Li Zhang, et al.
Respiratory Medicine (2025) Vol. 240, pp. 108024-108024
Closed Access
Chongyang Zhao, Gang Wang, Li Zhang, et al.
Respiratory Medicine (2025) Vol. 240, pp. 108024-108024
Closed Access
Identifying Super-Responders: a Review of the Road to Asthma Remission
Samuel Mailhot-Larouche, C.A. Celis-Preciado, Liam G. Heaney, et al.
Annals of Allergy Asthma & Immunology (2024)
Open Access | Times Cited: 4
Samuel Mailhot-Larouche, C.A. Celis-Preciado, Liam G. Heaney, et al.
Annals of Allergy Asthma & Immunology (2024)
Open Access | Times Cited: 4
The Potential Role of Nasal Cytology in Respiratory Diseases: Clinical Research and Future Perspectives
Giuseppina Marcuccio, Giuseppina Raffio, Pasquale Ambrosino, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 884-884
Open Access
Giuseppina Marcuccio, Giuseppina Raffio, Pasquale Ambrosino, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 884-884
Open Access
Biologics and biomarkers
L. Nair, Rohit Katial
Journal of Precision Respiratory Medicine (2025) Vol. 8, Iss. 1, pp. 3-8
Open Access
L. Nair, Rohit Katial
Journal of Precision Respiratory Medicine (2025) Vol. 8, Iss. 1, pp. 3-8
Open Access
Exploring the association between asthma and chronic comorbidities: impact on clinical outcomes
Aditya Sri Listyoko, Ryota Okazaki, Tomoya Harada, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
Aditya Sri Listyoko, Ryota Okazaki, Tomoya Harada, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
Navigating biologic therapies in elderly asthma
HyeIn Ji, Laren Tan, George W. Hafzalla, et al.
Respiratory Medicine (2024) Vol. 227, pp. 107655-107655
Closed Access | Times Cited: 3
HyeIn Ji, Laren Tan, George W. Hafzalla, et al.
Respiratory Medicine (2024) Vol. 227, pp. 107655-107655
Closed Access | Times Cited: 3
Difficult-To-Treat and Severe Asthma: Can Real-World Studies On Effectiveness of Biological Treatments Change the Lives of Patients?
Corrado Pelaia, Antonio Giacalone, Gianluca Ippolito, et al.
Pragmatic and Observational Research (2024) Vol. Volume 15, pp. 45-51
Open Access | Times Cited: 2
Corrado Pelaia, Antonio Giacalone, Gianluca Ippolito, et al.
Pragmatic and Observational Research (2024) Vol. Volume 15, pp. 45-51
Open Access | Times Cited: 2
Pre-asthma: a useful concept? A EUFOREA paper. Part 2—late onset eosinophilic asthma
Glenis Scadding, Claudia L. Gray, Diego M. Conti, et al.
Frontiers in Allergy (2024) Vol. 5
Open Access | Times Cited: 2
Glenis Scadding, Claudia L. Gray, Diego M. Conti, et al.
Frontiers in Allergy (2024) Vol. 5
Open Access | Times Cited: 2
Do Comorbidities Influence the Response to Biologics in Severe Asthma?
Corrado Pelaia, Girolamo Pelaia, William W. Busse
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 209, Iss. 3, pp. 233-235
Open Access | Times Cited: 4
Corrado Pelaia, Girolamo Pelaia, William W. Busse
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 209, Iss. 3, pp. 233-235
Open Access | Times Cited: 4
Aktuelles zum Asthma 2024 – was der HNO-Arzt wissen muss
Marek Lommatzsch, Georgios Rovas, A. Nastev, et al.
Laryngo-Rhino-Otologie (2024) Vol. 103, Iss. 03, pp. 219-230
Closed Access | Times Cited: 1
Marek Lommatzsch, Georgios Rovas, A. Nastev, et al.
Laryngo-Rhino-Otologie (2024) Vol. 103, Iss. 03, pp. 219-230
Closed Access | Times Cited: 1
Type 2 severe asthma: pathophysiology and treatment with biologics
Corrado Pelaia, J. Mark Melhorn, Timothy S.C. Hinks, et al.
Expert Review of Respiratory Medicine (2024) Vol. 18, Iss. 7, pp. 485-498
Closed Access | Times Cited: 1
Corrado Pelaia, J. Mark Melhorn, Timothy S.C. Hinks, et al.
Expert Review of Respiratory Medicine (2024) Vol. 18, Iss. 7, pp. 485-498
Closed Access | Times Cited: 1
Real-Life Response to Biologics in Severe Asthma with Nasal Polyposis: Insights from the Belgian Severe Asthma Registry
Femke Demolder, Eef Vanderhelst, Sylvia Verbanck, et al.
Lung (2024)
Closed Access | Times Cited: 1
Femke Demolder, Eef Vanderhelst, Sylvia Verbanck, et al.
Lung (2024)
Closed Access | Times Cited: 1
The Role of Biologics in Inducing Remission in Asthma
William W. Busse
Annals of Allergy Asthma & Immunology (2024)
Closed Access | Times Cited: 1
William W. Busse
Annals of Allergy Asthma & Immunology (2024)
Closed Access | Times Cited: 1
Childhood infections, asthma and allergy trajectories, and chronic rhinosinusitis in middle age: A prospective cohort study across six decades
Jennifer L. Perret, Nur Sabrina Idrose, E. Haydn Walters, et al.
Allergy (2024) Vol. 79, Iss. 10, pp. 2717-2731
Open Access
Jennifer L. Perret, Nur Sabrina Idrose, E. Haydn Walters, et al.
Allergy (2024) Vol. 79, Iss. 10, pp. 2717-2731
Open Access
Adherence to Systemic Therapy for Atopic Dermatitis in Adult Patients in Saudi Arabia: A Cross-Sectional Study
Ali M Aleid, Raghad Alharbi, Nafisah Al Radhwan, et al.
Cureus (2024)
Open Access
Ali M Aleid, Raghad Alharbi, Nafisah Al Radhwan, et al.
Cureus (2024)
Open Access
Factors Associated with Uncontrolled Severe Asthma in the Biologic Era
Hideki Yasui, Kyohei Oishi, Fumiya Nihashi, et al.
Respiratory Medicine (2024), pp. 107881-107881
Closed Access
Hideki Yasui, Kyohei Oishi, Fumiya Nihashi, et al.
Respiratory Medicine (2024), pp. 107881-107881
Closed Access
Precision medicine and choosing a biologic in asthma: understanding the current state of knowledge for predictors of response and clinical remission
Sadhana Balasubramanyam, Elizabeth George, Eileen Wang
Current Opinion in Allergy and Clinical Immunology (2024) Vol. 25, Iss. 1, pp. 66-74
Closed Access
Sadhana Balasubramanyam, Elizabeth George, Eileen Wang
Current Opinion in Allergy and Clinical Immunology (2024) Vol. 25, Iss. 1, pp. 66-74
Closed Access
Diagnostic value of nasal sinus computed tomography/magnetic resonance imaging examination and serum cytokines in unilateral benign sphenoid sinus lesions
Jianling Li, Rui Luo, Wei Gao
Journal of Radiation Research and Applied Sciences (2024) Vol. 18, Iss. 1, pp. 101187-101187
Closed Access
Jianling Li, Rui Luo, Wei Gao
Journal of Radiation Research and Applied Sciences (2024) Vol. 18, Iss. 1, pp. 101187-101187
Closed Access
Baseline Characteristics of Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry
Njira Lugogo, Xavier Soler, Yasuhiro Gon, et al.
Advances in Therapy (2024) Vol. 42, Iss. 2, pp. 849-862
Open Access
Njira Lugogo, Xavier Soler, Yasuhiro Gon, et al.
Advances in Therapy (2024) Vol. 42, Iss. 2, pp. 849-862
Open Access
Assessing the Underdiagnosis of Allergic Rhinitis Correlations with Asthma and Quality of Life in Saudi Paediatric Populations: A Cross-sectional Study
Kawthar Mohammed Aleid, Kawther Ibrahim Alhawsawi, Amani Ahmed Mutaen, et al.
(2024) Vol. 1, Iss. 1, pp. 268-274
Closed Access
Kawthar Mohammed Aleid, Kawther Ibrahim Alhawsawi, Amani Ahmed Mutaen, et al.
(2024) Vol. 1, Iss. 1, pp. 268-274
Closed Access
